Aarts E O, Dogan K, Koehestanie P, Aufenacker Th J, Janssen I M C, Berends F J
Department of Surgery, Rijnstate Hospital, Arnhem, The Netherlands..
Department of Surgery, Rijnstate Hospital, Arnhem, The Netherlands.
Surg Obes Relat Dis. 2014 Jul-Aug;10(4):633-40. doi: 10.1016/j.soard.2014.03.019. Epub 2014 Apr 5.
For over a decade, the laparoscopic adjustable gastric band (LAGB) was 1 of the most performed bariatric procedures in Europe. This study is a retrospective analysis with prospectively collected data of the experience in 1 specialized Dutch center with the adjustable gastric band over 14 years.
Between 1995 and 2003, 201 patients underwent an LAGB for morbid obesity in our hospital. Data on preoperative clinical characteristic, postoperative outcome and weight loss patterns, and co-morbidities for up to 18 years are presented and evaluated using the Bariatric Analysis and Reporting Outcome System (BAROS).
Average follow-up was 13.6 (± 2.0) years (163 mo) and 99% of patients with complete follow-up. Two thirds of patients reached an excess weight loss (EWL)>50% at some point after LAGB placement. However, due to insufficient weight loss or complications in 53% of patients, the LAGB had to be removed or converted to a Roux-en-Y gastric bypass. Additionally, half of the remaining patients had disappointing results according to the BAROS score. In total, less than one quarter (22%) of patients had a functioning band with a good result after the follow-up period. Although initially the number of patients experiencing co-morbidities was reduced, most of them returned and a large number of patients developed new co-morbidities. Complications, other than weight regain, were numerous as 47% of patients experienced at least 1. In total, 204 reoperations were performed in 137 (68%) patients. Furthermore, patients who were lost to follow-up did almost twice as bad in terms of EWL compared to patients who had regular follow-up.
Morbid obesity is a chronic disease that can be resolved with bariatric surgery. One of the treatment options is the LAGB, which in the short term shows good results in terms of EWL and co-morbidity reduction. In the long term, however, EWL and co-morbidity reduction are disappointing, and the LAGB does not seem to live up to expectations. Besides the decrease in EWL over time, the number of reoperations required is alarming. In total, less than a quarter of patients still had a functioning band after a mean 14 years of follow-up.
十多年来,腹腔镜可调节胃束带术(LAGB)一直是欧洲实施最多的减肥手术之一。本研究是一项回顾性分析,前瞻性收集了荷兰一家专业中心14年来使用可调节胃束带的经验数据。
1995年至2003年期间,我院201例患者因病态肥胖接受了LAGB手术。使用减肥分析和报告结果系统(BAROS)呈现并评估术前临床特征、术后结果和体重减轻模式以及长达18年的合并症数据。
平均随访时间为13.6(±2.0)年(163个月),99%的患者有完整随访。三分之二的患者在放置LAGB后的某个时间点超重减轻(EWL)>50%。然而,由于53%的患者体重减轻不足或出现并发症,LAGB不得不被移除或转换为 Roux-en-Y 胃旁路术。此外,根据BAROS评分,其余一半患者的结果令人失望。随访期结束后,总共不到四分之一(22%)的患者胃束带功能良好且效果良好。虽然最初出现合并症的患者数量有所减少,但大多数又复发了,并且大量患者出现了新的合并症。除体重反弹外,并发症很多,47%的患者至少经历过1次。总共137例(68%)患者进行了204次再次手术。此外,失访患者的EWL情况与定期随访患者相比几乎差了一倍。
病态肥胖是一种可通过减肥手术解决的慢性疾病。治疗选择之一是LAGB,它在短期内EWL和合并症减少方面显示出良好效果。然而,从长期来看,EWL和合并症减少情况令人失望,LAGB似乎未达预期。除了EWL随时间下降外,所需再次手术的数量也令人担忧。平均随访14年后,总共不到四分之一的患者胃束带仍在发挥作用。